Royal Bank of Canada’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $78K | Sell |
25,317
-2,097
| -8% | -$8.9K | ﹤0.01% | 5260 |
|
|
2025
Q4 | $99K | Sell |
27,414
-39,319
| -59% | -$171K | ﹤0.01% | 5198 |
|
|
2025
Q3 | $251K | Buy |
66,733
+5,770
| +9% | +$22.3K | ﹤0.01% | 4938 |
|
|
2025
Q2 | $236K | Buy |
60,963
+8,496
| +16% | +$46K | ﹤0.01% | 5035 |
|
|
2025
Q1 | $262K | Sell |
52,467
-4,061
| -7% | -$25.7K | ﹤0.01% | 4501 |
|
|
2024
Q4 | $407K | Buy |
56,528
+19,409
| +52% | +$148K | ﹤0.01% | 4233 |
|
|
2024
Q3 | $228K | Buy |
37,119
+6,107
| +20% | +$41.4K | ﹤0.01% | 4713 |
|
|
2024
Q2 | $205K | Sell |
31,012
-8,863
| -22% | -$65.4K | ﹤0.01% | 4750 |
|
|
2024
Q1 | $406K | Sell |
39,875
-52,216
| -57% | -$531K | ﹤0.01% | 4122 |
|
|
2023
Q4 | $1.03M | Buy |
92,091
+83,701
| +998% | +$349K | ﹤0.01% | 3647 |
|
|
2023
Q3 | $22K | Sell |
8,390
-10,648
| -56% | -$30.5K | ﹤0.01% | 6136 |
|
|
2023
Q2 | $66K | Buy |
19,038
+7,347
| +63% | +$33K | ﹤0.01% | 5625 |
|
|
2023
Q1 | $49K | Buy |
11,691
+10,564
| +937% | +$126K | ﹤0.01% | 5630 |
|
|
2022
Q4 | $18K | Sell |
1,127
-1,339
| -54% | -$15K | ﹤0.01% | 6337 |
|
|
2022
Q3 | $31K | Sell |
2,466
-5,827
| -70% | -$86K | ﹤0.01% | 5959 |
|
|
2022
Q2 | $97K | Buy |
8,293
+5,699
| +220% | +$35.1K | ﹤0.01% | 5345 |
|
|
2022
Q1 | $16K | Sell |
2,594
-6,018
| -70% | -$44.3K | ﹤0.01% | 6709 |
|
|
2021
Q4 | $78K | Buy |
8,612
+2,143
| +33% | +$22.8K | ﹤0.01% | 6104 |
|
|
2021
Q3 | $73K | Buy |
6,469
+2,482
| +62% | +$30.2K | ﹤0.01% | 5921 |
|
|
2021
Q2 | $39K | Buy |
3,987
+3,800
| +2,032% | +$52K | ﹤0.01% | 6196 |
|
|
2021
Q1 | $3K | Buy |
+187
| New | +$3.02K | ﹤0.01% | 7140 |
|
|
2020
Q4 | – | Sell |
-113
| Closed | -$1K | – | 7042 |
|
|
2020
Q3 | $1K | Sell |
113
-267
| -70% | -$5.34K | ﹤0.01% | 6384 |
|
|
2020
Q2 | $4K | Hold |
380
| – | – | ﹤0.01% | 6085 |
|
|
2020
Q1 | $1K | Buy |
+380
| New | +$874 | ﹤0.01% | 6392 |
|
|
2019
Q4 | – | Sell |
-355
| Closed | -$1K | – | 6779 |
|
|
2019
Q3 | $1K | Buy |
+355
| New | +$787 | ﹤0.01% | 6388 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6484 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6302 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6503 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6680 |
|
|
2017
Q2 | – | Sell |
-5
| Closed | -$1K | – | 6540 |
|
|
2017
Q1 | $1K | Sell |
5
-8
| -62% | -$4.28K | ﹤0.01% | 6494 |
|
|
2016
Q4 | $12K | Buy |
+13
| New | +$11.6K | ﹤0.01% | 5999 |
|
|
2016
Q2 | – | Sell |
-3
| Closed | -$2K | – | 6347 |
|
|
2016
Q1 | $2K | Hold |
3
| – | – | ﹤0.01% | 6110 |
|
|
2015
Q4 | $2K | Sell |
3
-1
| -25% | -$499 | ﹤0.01% | 6345 |
|
|
2015
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 6455 |
|
|
2015
Q2 | $2K | Buy |
4
+1
| +33% | +$505 | ﹤0.01% | 6360 |
|
|
2015
Q1 | $2K | Hold |
3
| – | – | ﹤0.01% | 5897 |
|
|
2014
Q4 | $2K | Hold |
3
| – | – | ﹤0.01% | 5960 |
|
|
2014
Q3 | $2K | Hold |
3
| – | – | ﹤0.01% | 5786 |
|
|
2014
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 5794 |
|
|
2014
Q1 | $2K | Hold |
3
| – | – | ﹤0.01% | 5723 |
|
|
2013
Q4 | $2K | Hold |
3
| – | – | ﹤0.01% | 5760 |
|
|
2013
Q3 | $2K | Hold |
3
| – | – | ﹤0.01% | 5843 |
|
|
2013
Q2 | $2K | Buy |
+3
| New | +$1.49K | ﹤0.01% | 5605 |
|
Other funds holding ALT
VCM
VPM
N
Royal Bank of Canada's ALT Position: Q1 2026 in Review
Royal Bank of Canada reduced its Altimmune (ALT) stake by 7.6% in Q1 2026, selling an estimated $8.9K and leaving 25,317 shares worth $78K. The position accounts for ﹤0.01% of the portfolio, ranked #5260.
Royal Bank of Canada first reported a position in ALT in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.03M in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.
- Royal Bank of Canada held 25,317 shares of Altimmune worth $78K as of Q1 2026.
- Royal Bank of Canada sold 2,097 Altimmune shares in Q1 2026, an estimated $8.9K.
- Altimmune made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5260 holding.
- Royal Bank of Canada first reported a position in Altimmune in Q2 2013 and has held it in 39 quarters since.
- Royal Bank of Canada's Altimmune position peaked at $1.03M in Q4 2023.
- 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.